» Articles » PMID: 19278795

Subtypes of Nonmedical Prescription Drug Misuse

Overview
Publisher Elsevier
Specialty Psychiatry
Date 2009 Mar 13
PMID 19278795
Citations 90
Authors
Affiliations
Soon will be listed here.
Abstract

This study used three characteristics (i.e., motive, route of administration, and co-ingestion with alcohol) of nonmedical prescription drug misuse across four separate classes (i.e., pain, sedative/anxiety, sleeping, and stimulant medications) to examine subtypes and drug related problems. A Web survey was self-administered by a randomly selected sample of 3639 undergraduate students attending a large midwestern 4-year U.S. university. Self-treatment subtypes were characterized by motives consistent with the prescription drug's pharmaceutical main indication, oral only routes of administration, and no co-ingestion with alcohol. Recreational subtypes were characterized by recreational motives, oral or non-oral routes, and co-ingestion. Mixed subtypes consisted of other combinations of motives, routes, and co-ingestion. Among those who reported nonmedical prescription drug misuse, approximately 13% were classified into the recreational subtype, while 39% were in the self-treatment subtype, and 48% were in the mixed subtype. There were significant differences in the subtypes in terms of gender, race and prescription drug class. Approximately 50% of those in subtypes other than self-treatment screened positive for drug abuse. The odds of substance use and abuse were generally lower among self-treatment subtypes than other subtypes. The findings indicate subtypes should be considered when examining nonmedical prescription drug misuse, especially for pain medication.

Citing Articles

Differential etiologic associations of heroin use and prescription opioid misuse with psychopathology.

Dash G, Gizer I, Martin N, Slutske W J Psychopathol Clin Sci. 2024; 133(5):378-391.

PMID: 38815084 PMC: 11869234. DOI: 10.1037/abn0000921.


Everybody's Doing It: Initiation to Prescription Drug Misuse.

Mui H, Sales P, Murphy S J Drug Issues. 2024; 44(3):236-253.

PMID: 38318234 PMC: 10843830. DOI: 10.1177/0022042613497935.


Predicting first use of heroin from prescription opioid use subtypes: Insights from the Monitoring the Future longitudinal panel.

Dash G, Gizer I, Slutske W Drug Alcohol Depend. 2024; 255:111084.

PMID: 38232646 PMC: 10842745. DOI: 10.1016/j.drugalcdep.2024.111084.


Initial validation of the expectancies for Benzodiazepine Analgesia Scale.

Lape E, Powers J, LaRowe L, Ditre J Exp Clin Psychopharmacol. 2023; 32(3):369-378.

PMID: 38010761 PMC: 11098706. DOI: 10.1037/pha0000692.


Medical and nonmedical use of psychiatric medications among medical students in Riyadh, Saudi Arabia.

Alswayed K, Alshuaibi S, Alsayegh H, Bin Shulhub A, Alsultan R, AlKhudhair M J Family Med Prim Care. 2022; 11(4):1455-1461.

PMID: 35516669 PMC: 9067198. DOI: 10.4103/jfmpc.jfmpc_1720_21.


References
1.
French M, Roebuck M, McGeary K, Chitwood D, McCoy C . Using the drug abuse screening test (DAST-10) to analyze health services utilization and cost for substance users in a community-based setting. Subst Use Misuse. 2001; 36(6-7):927-46. DOI: 10.1081/ja-100104096. View

2.
McCabe S, Cranford J, Morales M, Young A . Simultaneous and concurrent polydrug use of alcohol and prescription drugs: prevalence, correlates, and consequences. J Stud Alcohol. 2006; 67(4):529-37. PMC: 1761923. DOI: 10.15288/jsa.2006.67.529. View

3.
Compton W, Volkow N . Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend. 2005; 81(2):103-7. DOI: 10.1016/j.drugalcdep.2005.05.009. View

4.
Mayfield D, McLeod G, Hall P . The CAGE questionnaire: validation of a new alcoholism screening instrument. Am J Psychiatry. 1974; 131(10):1121-3. DOI: 10.1176/ajp.131.10.1121. View

5.
Kroutil L, Van Brunt D, Herman-Stahl M, Heller D, Bray R, Penne M . Nonmedical use of prescription stimulants in the United States. Drug Alcohol Depend. 2006; 84(2):135-43. DOI: 10.1016/j.drugalcdep.2005.12.011. View